Inventor · disambiguated record
Rajendra Tandale
Also filed as: TANDALE RAJENDRA · TANDALE RAJENDRA S
5 granted patents·4 pending applications·57 citations·filing 2007–2025
79Inventor score
Files withUNICYCIVE THERAPEUTICS INC3APPLIED MOLECULAR TRANSPORT INC2GENENTECH INC1INHERIS BIOPHARMA INC1SINGH AMARJIT1
Top patents by PatentIndex Score
9 records- 0193US11160869B2Compositions, formulations and interleukin production and purificationAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Granted Nov 2, 2021·4 cites·25 claims
- 0291US10350240B2Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and useSPECTRUM PHARMACEUTICALS INC·Filed 2013·Granted Jul 16, 2019·27 cites·20 claims
- 0390US11479593B2Compositions, formulations and interleukin production and purificationAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Granted Oct 25, 2022·1 cites·30 claims
- 0487US8277843B2Programmable buoyant delivery technologySINGH AMARJIT·Filed 2007·Granted Oct 2, 2012·25 cites·47 claims
- 0579US2025288608A1Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and useUNICYCIVE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0673US2022347210A1Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and UseUNICYCIVE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0771US11406663B2Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and useUNICYCIVE THERAPEUTICS INC·Filed 2019·Granted Aug 9, 2022·0 cites·17 claims
- 0857US2020361933A1Pharmaceutical compound, salts thereof, formulations thereof, and methods of making and using sameGENENTECH INC·Filed 2019·Application pending·0 cites
- 0937US2021085672A1Oral tablet formulationsINHERIS BIOPHARMA INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rajendra Tandale files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →